The effects of gold nanoparticles on the human blood functions

References

• Abadeer NS, Murphy CJ. Recent progress in cancer thermal therapy using gold nanoparticles. J Phys Chem C. 2016;120:4691–4716.
   Web of Science ®Google Scholar
• Kafshdooz L, Kafshdooz T, Razban Z, et al. The application of gold nanoparticles as a promising therapeutic approach in breast and ovarian cancer. Artif Cells Nanomed Biotechnol. 2015;44:1222–1227.
   PubMed Web of Science ®Google Scholar
• Weaver JL, Tobin GA, Ingle T, et al. Evaluating the potential of gold, silver, and silica nanoparticles to saturate mononuclear phagocytic system tissues under repeat dosing conditions. Part Fibre Toxicol. 2017;14:25.
   PubMed Web of Science ®Google Scholar
• Daraee H, Eatemadi A, Abbasi E, et al. Application of gold nanoparticles in biomedical and drug delivery. Artif Cells Nanomed Biotechnol. 2016;44:410–422.
   PubMed Web of Science ®Google Scholar
• Senut MC, Zhang YH, Liu FC, et al. Size-dependent toxicity of gold nanoparticles on human embryonic stem cells and their neural derivatives. Small. 2016;12:631–646.
   PubMed Web of Science ®Google Scholar
• Shrivastava R, Kushwaha P, Bhutia YC, et al. Oxidative stress following exposure to silver and gold nanoparticles in mice. Toxicol Ind Health. 2016;32:1391–1404.
   PubMed Web of Science ®Google Scholar
• Harris JM, Martin NE, Modi M. Pegylation: a novel process for modifying pharmacokinetics. Clin Pharmacokinetics. 2001;40:539–551.
   PubMed Web of Science ®Google Scholar
• Kah JC, Wong KY, Neoh KG, et al. Critical parameters in the pegylation of gold nanoshells for biomedical applications: an in vitro macrophage study. J Drug Target. 2009;17:181–193.
   PubMed Web of Science ®Google Scholar
• Davis ME, Zuckerman JE, Choi CH, et al. Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature. 2010;464:1067–1070.
   PubMed Web of Science ®Google Scholar
• Liu Z, Li W, Wang F, et al. Enhancement of lipopolysaccharide-induced nitric oxide and interleukin-6 production by PEGylated gold nanoparticles in RAW264.7 cells. Nanoscale. 2012;4:7135–7142.
   PubMed Web of Science ®Google Scholar
• Cho WS, Cho M, Jeong J, et al. Size-dependent tissue kinetics of PEG-coated gold nanoparticles. Toxic Appl Pharm. 2010;245:116–123.
   PubMed Web of Science ®Google Scholar
• He Z, Liu J, Du L. The unexpected effect of PEGylated gold nanoparticles on the primary function of erythrocytes. Nanoscale. 2014;6:9017–9024.
   PubMed Web of Science ®Google Scholar
• Dykman L, Khlebtsov N. Gold nanoparticles in biomedical applications: recent advances and perspectives. Chem Soc Rev. 2014;41:2256–2282.
   Web of Science ®Google Scholar
• Du L, Suo S, Wang G, et al. Mechanism and cellular kinetic studies of the enhancement of antioxidant activity by using surface-functionalized gold nanoparticles. Chem Eur J. 2013;19:1281–1287.
   PubMed Web of Science ®Google Scholar
• Ma L, Sun P, Lin F, et al. In vitro evaluation of residual procoagulants in human intravenous immunoglobulins from 11 Chinese blood fractionation companies. Thromb Res. 2013;132:381–385.
   PubMed Web of Science ®Google Scholar
• Roberts RL, Gallin JI. Rapid method for isolation of normal human peripheral blood eosinophils on discontinuous Percoll gradients and comparison with neutrophils. Blood. 1985;65:433–440.
   PubMed Web of Science ®Google Scholar
• Ungerer M, Rosport K, Bultmann A, et al. Novel antiplatelet drug revacept (Dimeric Glycoprotein VI-Fc) specifically and efficiently inhibited collagen-induced platelet aggregation without affecting general hemostasis in humans. Circulation. 2011;123:1891–1899.
   PubMed Web of Science ®Google Scholar
• Pennings GJ, Siegwald J, Yong AS, et al. Resident performed two-point compression ultrasound is inadequate for diagnosis of deep vein thrombosis in the critically III. J Thromb Thrombolysis. 2014;37:326–330.
   PubMed Web of Science ®Google Scholar
• Chung T, Connor D, Joseph J, et al. Platelet activation in acute pulmonary embolism. J Thromb Haemost. 2007;5:918–924.
   PubMed Web of Science ®Google Scholar
• Stang K, Fennrich S, Krajewski S, et al. Highly sensitive pyrogen detection on medical devices by the monocyte activation test. J Mater Sci: Mater Med. 2014;25:1065–1075.
   PubMed Web of Science ®Google Scholar
• Piella J, Bastús NG, Puntes V. Size-dependent protein-nanoparticle interactions in citrate-stabilized gold nanoparticles: the emergence of the protein corona. Bioconjugate Chem. 2017;28:88–97.
   PubMed Web of Science ®Google Scholar
• Alcantar NA, Aydil ES, Israelachvili JN. Polyethylene glycol-coated biocompatible surfaces. J Biomed Mater Res. 2000;51:343–351.
   PubMed Web of Science ®Google Scholar
• Dobrovolskaia MA, McNeil SE. Immunological properties of engineered nanomaterials. Nature Nanotech. 2007;2:469–478.
   PubMed Web of Science ®Google Scholar
• Wang Z, Li J, Cho J, et al. Prevention of vascular inflammation by nanoparticle targeting of adherent neutrophils. Nature Nanotech. 2014;9:204–210.
   PubMed Web of Science ®Google Scholar
• Chen S, Chen S, Zeng Y, et al. Size-dependent superparamagnetic iron oxide nanoparticles dictate interleukin-1β release from mouse bone marrow-derived macrophages. J Appl Toxicol. 2018;38:1–9.
   Web of Science ®Google Scholar
• Dinarello CA. Biologic basis for interleukin-1 in disease. Blood. 1996;87:2095–2147.
   PubMed Web of Science ®Google Scholar
• Radomski A, Jurasz P, Alonso-Escolano D, et al. Nanoparticle-induced platelet aggregation and vascular thrombosis. Br J Pharmacol. 2005;146:882–893.
   PubMed Web of Science ®Google Scholar
• Coller BS. Blockade of platelet GP IIb/IIIa receptors as an antithrombotic strategy. Circulation. 1995;92:2373–2380.
   PubMed Web of Science ®Google Scholar